Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P010014/S119

Cementless Oxford Partial Knee System

Biomet Manufacturing Corp · Decision date Oct 6, 2026

MEDTECHLEDGER EXPLANATIONP010014/S119

What did the FDA decide?

The FDA record lists P010014/S119 as a 30-day notice for the Cementless Oxford Partial Knee System, with decision OK30 dated 2026-10-06 and applicant Biomet Manufacturing Corp. The stated change is introduction of an additional Solvent Wash Step to the final cleaning of the femoral and tibial components at the Shannon, Ireland facility; the supplement reason is a process change covering manufacturer, sterilizer, packager or supplier.

The identifier places S119 as a supplement within PMA P010014, not a new approval of the whole knee system, and the notice concerns cleaning-process scope rather than a clinical claim. The record gives no solvent identity, wash parameters, validation data or residue limits. The reported purpose is a manufacturing change; the entry alone does not prove safety or clinical effectiveness of the resulting components.

FDA approval order statement

introduction of an additional Solvent Wash Step to the final cleaning of the femoral and tibial components of the Oxford Cementless Partial Knee System at the Shannon, Ireland facility
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Orthopedic
Decision date
Oct 6, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P010014/S119
Regulatory pathway
PMA supplement
Product code
NRA
Decision code
OK30
Decision date
Oct 6, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, knee, femorotibial, unicompartmental, semi-constrained, metal/polymer, mobile bearing.

Product code
NRA
FDA device class
3

For the original device and its historical approval scope, see PMA P010014. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P010014 · Original PMA

    OXFORD(TM) MENISCAL UNICOMPARTMENTAL KNEE SYSTEM

  2. P010014/S119 received

    Application receipt date recorded by FDA.

  3. P010014/S118 · Related supplement

    Oxford Partial Knee Anatomic Vivacit-E Meniscal Bearings

  4. P010014/S119 · FDA decision

    30-Day Notice

  5. P010014/S120 · Related supplement

    Oxford Partial Knee System

Timeline entries are records held by MedtechLedger for P010014. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P010014

Product / regulatory recordCompanyPathwayDecision dateSource
Biomet Manufacturing CorpPMA approvalApr 21, 2004FDA
Biomet Manufacturing CorpPMA supplementSep 1, 2026FDA
Biomet Manufacturing CorpPMA supplementOct 26, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biomet Manufacturing Corp

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
56 E. Bell Dr.,, P.O. Box 587, Warsaw, IN, 46581

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records